NYSE:CAH - New York Stock Exchange, Inc. - US14149Y1082 - Common Stock - Currency: USD
CARDINAL HEALTH INC
NYSE:CAH (1/31/2025, 8:15:29 PM)
After market: 123.66 0 (0%)123.66
-4.6 (-3.59%)
The current stock price of CAH is 123.66 USD. In the past month the price increased by 4.56%. In the past year, price increased by 19.52%.
Healthcare distributor and services company Cardinal Health (NYSE:CAH) beat Wall Street’s revenue expectations in Q4 CY2024, but sales fell by 3.8% year on year to $55.26 billion. Its non-GAAP profit of $1.93 per share was 9.4% above analysts’ consensus estimates.
Healthcare distributor and services company Cardinal Health (NYSE:CAH) beat Wall Street’s revenue expectations in Q4 CY2024, but sales fell by 3.8% year on year to $55.26 billion. Its non-GAAP profit of $1.93 per share was 9.4% above analysts’ consensus estimates.
Revenue decreased 4% to $55.3 billion; revenue increased 16% excluding the impact of the previously communicated large customer contract expiration GAAP1...
U.S. House Representative Marjorie Taylor Greene has disclosed new trades as Donald Trump's equations evolves with Big Tech leaders.
/PRNewswire/ -- Cardinal Health (NYSE: CAH) announced construction is underway on a new distribution center in Fort Worth, Texas, which will support its...
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
MCK | MCKESSON CORP | 20.6 | 75.50B | ||
COR | CENCORA INC | 18.47 | 49.13B | ||
HSIC | HENRY SCHEIN INC | 19 | 9.97B | ||
PDCO | PATTERSON COS INC | 14.6 | 2.73B | ||
AHCO | ADAPTHEALTH CORP | N/A | 1.46B | ||
OMI | OWENS & MINOR INC | 8.58 | 1.10B | ||
AHG | AKSO HEALTH GROUP | N/A | 510.49M | ||
COSM | COSMOS HEALTH INC | N/A | 16.47M | ||
VRAX | VIRAX BIOLABS GROUP LTD | N/A | 7.33M | ||
ATPC | AGAPE ATP CORP | N/A | 5.59M |
Cardinal Health, Inc. is a healthcare services and products company, which engages in the provision of customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, and physician offices. The company is headquartered in Dublin Ohio, Ohio and currently employs 48,900 full-time employees. The firm is engaged in providing customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices and patients in the home. The firm also provides pharmaceuticals and medical products. The Company’s segments include Pharmaceutical and Specialty Solutions and Global Medical Products and Distribution (GMPD). The Pharmaceutical and Specialty Solutions segment distributes branded and generic pharmaceuticals, specialty pharmaceuticals and over-the-counter healthcare and consumer products in the United States. Its GMPD segment manufactures, sources and distributes Cardinal Health branded medical, surgical and laboratory products, which are sold in the United States, Canada, Europe, Asia and other markets. The firm connects patients, providers, payers, pharmacists and manufacturers for integrated care coordination.
CARDINAL HEALTH INC
7000 Cardinal Pl
Dublin Ohio OHIO 43017 US
CEO: Michael C. Kaufmann
Employees: 48411
Company Website: https://www.cardinalhealth.com/en.html
Investor Relations: https://ir.cardinalhealth.com/
Phone: 16147573033
The current stock price of CAH is 123.66 USD.
The exchange symbol of CARDINAL HEALTH INC is CAH and it is listed on the New York Stock Exchange, Inc. exchange.
CAH stock is listed on the New York Stock Exchange, Inc. exchange.
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for CAH, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of CAH.
CAH has a dividend yield of 1.55%. The yearly dividend amount is currently 2.02.
The PE ratio for CAH is 16. This is based on the reported non-GAAP earnings per share of 7.73 and the current share price of 123.66 USD.
The outstanding short interest for CAH is 1.75% of its float.
ChartMill assigns a technical rating of 8 / 10 to CAH. When comparing the yearly performance of all stocks, CAH is one of the better performing stocks in the market, outperforming 72.85% of all stocks.
ChartMill assigns a fundamental rating of 5 / 10 to CAH. Both the profitability and the financial health of CAH get a neutral evaluation. Nothing too spectacular is happening here.
Over the last trailing twelve months CAH reported a non-GAAP Earnings per Share(EPS) of 7.73. The EPS increased by 13.01% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 0.56% | ||
ROA | 2.93% | ||
ROE | N/A | ||
Debt/Equity | N/A |
ChartMill assigns a Buy % Consensus number of 75% to CAH. The Buy consensus is the average rating of analysts ratings from 22 analysts.
For the next year, analysts expect an EPS growth of 6.22% and a revenue growth -2.36% for CAH